MicroRNAs expression profiles as diagnostic biomarkers of gastric cancer: a systematic literature review

Jovana Stojanovic, Alessia Tognetto, Danilo Francesco Tiziano, Emanuele Leoncini, Brunella Posteraro, Roberta Pastorino, Stefania Boccia

Research output: Contribution to journalArticlepeer-review


OBJECTIVE: The early identification of gastric cancer (GC) represents a major clinical challenge. We conducted a systematic review of studies evaluating the miRNA expression profiling as a diagnostic tool in GC.

METHODS: We performed a search of PubMed, ISI Web of Science and SCOPUS databases for studies on diagnostic miRNAs and GC, published in English up to October 2017. Eligibility criteria included case-control studies evaluating blood or tissue-based miRNA expression profiles, and incorporating at least two detection phases (screening and validation).

RESULTS: We included 27 eligible studies, that reported on 97 deregulated miRNAs either in blood or tissue, out of which 30 were reported in at least two studies. Among 22 studies on tissue-diagnostic miRNAs, 13 consistently upregulated miRNAs (miR-214, miR-21, miR-103, miR-107, miR-196a, miR-196b, miR-7, miR-135b, miR-222, miR-23b, miR-25, miR-92 and miR-93), and six consistently downregulated miRNAs (miR-148a, miR-375, miR-133b, miR-30a, miR-193a and miR-204) were reported. Ten miRNAs with inconsistent direction of expression in tissues were identified. Among the five studies performed on blood samples, only one miRNA was consistently upregulated (miR-20a).

CONCLUSIONS: This review shows that some tissue or blood miRNAs may be considered as potential biomarkers for GC diagnosis, that urgently needs to be confirmed from large prospective studies.

Original languageEnglish
Pages (from-to)1-10
Number of pages10
Publication statusE-pub ahead of print - Nov 2 2018


Dive into the research topics of 'MicroRNAs expression profiles as diagnostic biomarkers of gastric cancer: a systematic literature review'. Together they form a unique fingerprint.

Cite this